BioLife Solutions, Inc.(NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management will participate in the following investor conferences during November and December:
https://mma.prnewswire.com/media/1533257/BioLife_Solutions_Logo.jpg
— Raymond James Napa Small Cap Symposium
— November 17, 2025
— Napa Valley at TheMeritage
— Stephens Annual Investment Conference
— November 18-20, 2025
— Nashville at the GrandHyatt Nashville
— Jefferies Global Healthcare Conference
— November 17-20, 2025
— London at TheWaldorf Hilton
— Furey Research Partners Hidden Gems Conference
— November 24-25, 2025
— Virtual
— Wolfe Research Small & Mid-Cap Conference
— December 2-3, 2025
— Virtual
— Northland Growth Conference 2025
— December 16, 2025
— Virtual
The BioLife Solutions Investor Presentation, reflecting the recently refreshed corporate branding, is now availableon the Investor Relationssection of the company's website.
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the CompanyTroy WichtermanChief Financial Officer(425) 402-1400twichterman@biolifesolutions.com
InvestorsAlliance Advisors IRJody Cain(310) 691-7100jcain@allianceadvisors.com
https://edge.prnewswire.com/c/img/favicon.png?sn=LA25645&sd=2025-11-17
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-november-and-december-2025-302617059.html
SOURCE BioLife Solutions, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=LA25645&Transmission_Id=202511170715PR_NEWS_USPR_____LA25645&DateId=20251117